glp-1 drugs insurance coverage Cigna is ending employee for weight-loss like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Perspectives from employers on the
Description
Given that they will be NPO for 6 hours prior to the sedation procedure, they should withhold these other diabetic medications as well on the day of the sedation appointment
This provides some comfort that the use of DPP-4 inhibitors by patients is unlikely to confer additional heart risk from these drugs [35]

For example, Ozempic is subsidised only for type 2 diabetes and not for weight loss

So theres a lot of studies going on of, like, Okay, what happens to peoples health benefits that you see
